UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029868
Receipt number R000033799
Scientific Title The effect of hip flexor muscles on hip joint extension angle during the late stance phase in walking
Date of disclosure of the study information 2017/11/07
Last modified on 2020/05/10 18:28:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of hip flexor muscles on hip joint extension angle during the late stance phase in walking

Acronym

The effect of hip flexor muscles on hip joint extension angle during the late stance phase in walking

Scientific Title

The effect of hip flexor muscles on hip joint extension angle during the late stance phase in walking

Scientific Title:Acronym

The effect of hip flexor muscles on hip joint extension angle during the late stance phase in walking

Region

Japan


Condition

Condition

healthy adult and elderly persons

Classification by specialty

Rehabilitation medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is as follows;
1.To measure the kinematic and kinetic parameters of hip joint and ankle joint during the late stance phase of walking in healthy adults and clarify the relationship between them.
2.To clarify the relationship between the maximum dynamic extension angle and the maximum passive extension angle of the hip joint in the late stance phase of walking
3.To investigate whether the reduction of hip flexion muscle strength causes a decrease in the maximal dynamic extension angle of the hip joint in the late stance of walking, or whether the increase in this muscular strength increases its extension angle.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

This study is an intervention study that performs muscle strengthening training of the hip flexor muscles for 6 weeks.
The primary outcome is the maximum dynamic extension angle of the hip joint in the late stance phase of walking.
The evaluation items are the kinematic and kinetic parameters of hip joint and ankle joint in the late stance phase of walking.
The evaluation is made before and after intervention.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Contents of the intervention are as follows;
1.Intervention period: 6 weeks
2.Exercise style: muscle strengthening training of hip flexor muscles.
3.Exercise method:
1 set: in standing posture, flexion of hip joint in 3 seconds (concentric contraction) , hold posture after flexion for 2 seconds (isometric contraction) , slowly return to the original posture in 3 seconds (eccentric contraction)
4.Number of exercises: 3 sets at a time. 2 minutes break between sets.
5.Exercise intensity: Three kinds of sera bands with different tension are used. Every two weeks to strengthen the load from a weak tension sera band to a strong sera band.
6.Frequency of exercise: Three times a week.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Selection criteria are as follows;
1.the age is an adult (including elderly), 2.the participants are willing to cooperate as a volunteer, 3.the participants are agreeing to participate in research is there.

Key exclusion criteria

Exclusion criteria are as follows;
1. Persons who have the history of operation for lower limb exercise disease in the past
2. Persons who have the physical exercising pain that interferes with research on lower back pain and lower extremity joint pain
3. Persons whose appearance abnormal attitude and abnormal walking are remarkable
4. Persons who has the disease that can't tolerate exercise at the time of intervention (muscle strengthening training) and before and after intervention (various measurements, walking)

Target sample size

75


Research contact person

Name of lead principal investigator

1st name Ryuichi
Middle name
Last name Sayra

Organization

Osaka Medical College

Division name

Department of Rehabilitation Medicine, Division of Comprehensive Medicine, Faculty of Medicine

Zip code

569-8686

Address

2-7 Daigaku-machi, Takatsuki, Osaka, Japan

TEL

072-683-1221

Email

saura@osaka-med.ac.jp


Public contact

Name of contact person

1st name Hisatomo
Middle name
Last name Sato

Organization

Osaka Medical College Hospital

Division name

Department of Rehabilitation

Zip code

569-8686

Address

2-7 Daigakumachi, Takatsuki, Osaka, Japan

TEL

072-683-1221

Homepage URL


Email

reh041@osaka.med.ac.jp


Sponsor or person

Institute

Osaka Medical College

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Medical University Research Ethics Committee

Address

Daigaku-machi, Takatsuki, Osaka, Japan

Tel

072-683-1221

Email

rinri@osaka-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 07 Day


Related information

URL releasing protocol

https://doi.org/10.1016/j.jos.2019.09.014

Publication of results

Published


Result

URL related to results and publications

https://doi.org/10.1016/j.jos.2019.09.014

Number of participants that the trial has enrolled

40

Results

Hip flexion strength increased from 1.68 to 1.95 Nm/kg and 1.04 to 1.21 Nm/kg in the healthy and the locomotive syndrome groups, respectively. The walking ability was increased in both groups. Consequently, the two-step test score improved from 1.17 to 1.30 and the stage of locomotive syndrome improved improved in 9 participants.

Results date posted

2020 Year 05 Month 10 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The healthy group had an age of 46.7 (14.9)years, a height of 163.4 (10.5) cm, a weight of 62.3 (11.0) kg, and a BMI of 23.3 (2.9).
The locomotive syndrome group had an age of 71.0 (11.4) years, a height of 154.2 (5.9) cm, a weight of 58.3 (7.7) kg, and a BMI of 24.5 (2.2). (mean(standard deviation))

Participant flow

A Two-step test score of 1.3 was established as the cutoff for locomotive syndrome(LS), 1.3 or more was considered to indicate being healthy, and less than 1.3 was considered to indicate LS. The healthy group was 24 and the locomotive syndrome group was 16. Participants performed hip flexor muscle training (intervention) for 6 weeks, but there were 2 dropouts in each group. Finally, 22 healthy groups and 14 LS groups were used for data analysis.

Adverse events

One participant stopped training due to lower back pain and two were excluded because they were hospitalized. In addition, one participant was excluded due to a lack of data.

Outcome measures

The main outcome are hip flexor muscles strength and the secondary outcome are walking ability and a stage of locomotive syndrome. The hip flexor muscles strength of the healthy group and the locomotive syndrome group was significantly improved (p <0.0001, p = 0.0031, respectively). Walking ability (left and right step length, stride length, walking speed) was significantly improved in both groups and a stage of locomotive syndrome was improved in the locomotive syndrome group (p = 0,041).

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2017 Year 10 Month 16 Day

Date of IRB

2017 Year 10 Month 10 Day

Anticipated trial start date

2017 Year 11 Month 07 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 11 Month 07 Day

Last modified on

2020 Year 05 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033799


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name